Clearing the Air: Summarizing the Smoking-related Relative Risks of Bladder and Kidney Cancer

European Urology

Volumn 70, Issue 3, 2016, Pages 467-468

  Purdue, Mark P ^a   Silverman, Debra T ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; CIGARETTE SMOKE; NICOTINE; TAR;

BLADDER CANCER; CANCER INCIDENCE; CANCER RISK; EDITORIAL; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; KIDNEY CANCER; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PUBLICATION; RISK ASSESSMENT; SMOKING; SMOKING CESSATION; SMOKING HABIT; SQUAMOUS CELL CARCINOMA; STUDY DESIGN; TOBACCO USE; BLADDER TUMOR; CARCINOGENESIS; INCIDENCE; KIDNEY TUMOR; RISK; SMOKE; TOBACCO;

CARCINOGENESIS; HUMANS; INCIDENCE; KIDNEY NEOPLASMS; RISK; SMOKE; SMOKING; TOBACCO; URINARY BLADDER NEOPLASMS;

EID: 84964669986     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2016.04.009     Document Type: Editorial

References (10)

1. [1] Freedman, N.D., Silverman, D.T., Hollenbeck, A.R., Schatzkin, A., Abnet, C.C., Association between smoking and risk of bladder cancer among men and women. JAMA 306 (2011), 737–745.
2. [2] Benichou, J., Chow, W.H., McLaughlin, J.K., Mandel, J.S., Fraumeni, J.F. Jr., Population attributable risk of renal cell cancer in Minnesota. Am J Epidemiol 148 (1998), 424–430.
3. [3] Cumberbatch, M.G., Rota, M., Catto, J.W.F., La Vecchia, C., The role of tobacco smoke in bladder and kidney carcinogenesis: a comparison of exposures and meta-analysis of incidence and mortality risks. Eur Urol 70 (2016), 458–466.
4. [4] Rothman, K.J., Greenland, S., Modern Epidemiology. ed 2., 1998, Lippincott-Raven, Philadelphia, PA.
5. [5] Silverman, D.T., Devesa, S.S., Moore, L.E., Rothman, N., Bladder cancer. Schottenfeld, D., Fraumeni, J.F. Jr., (eds.) Cancer Epidemiology and Prevention, ed 3., 2006, Oxford University Press, New York, NY, 1101–1127.
6. [6] Baris, D., Karagas, M.R., Verrill, C., et al. A case-control study of smoking and bladder cancer risk: emergent patterns over time. J Natl Cancer Inst 101 (2009), 1553–1561.
7. [7] Welty, C.J., Wright, J.L., Hotaling, J.M., Bhatti, P., Porter, M.P., White, E., Persistence of urothelial carcinoma of the bladder risk among former smokers: results from a contemporary, prospective cohort study. Urol Oncol, 32, 2014 25.e1–5.
8. [8] Bjerregaard, B.K., Raaschou-Nielsen, O., Sorensen, M., et al. Tobacco smoke and bladder cancer–in the European Prospective Investigation Into Cancer and Nutrition. Int J Cancer 119 (2006), 2412–2416.
9. [9] Hoffmann, D., Hoffmann, I., The changing cigarettes: chemical studies and bioassays. Shopland, D.R., Burns, D.M., Benowitz, N.L., Amacher, R.H., (eds.) Risk Associated With Smoking Cigarettes With Low Machine-Measured Yields of Tar and Nicotine. NIH Publication No. 02-5074, 2001, US National Institutes of Health, National Cancer Institute, Bethesda, MD, 159–191.
10. [10] Garcia-Closas, M., Rothman, N., Figueroa, J.D., et al. Common genetic polymorphisms modify the effect of smoking on absolute risk of bladder cancer. Cancer Res 73 (2013), 2211–2220.